Top Institutions in Ophthalmology - Retinal Diseases
Leading institutions conduct and analyze multi-year randomized controlled trials and extension studies on novel complement-inhibiting therapies for GA, integrating structural imaging and functional testing such as microperimetry to assess treatment efficacy and safety.
-
#100
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research and clinical trials, including pivotal studies on geographic atrophy and novel therapeutics like pegcetacoplan. Their expertise in advanced retinal imaging and functional assessment supports comprehensive evaluation of treatment outcomes.
-
#92
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is renowned for its clinical research in retinal degenerations and age-related macular degeneration, contributing significantly to understanding GA progression and treatment effects with complement inhibitors.
-
#88
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute integrates basic science and clinical research in retinal diseases, focusing on complement pathway modulation and long-term functional preservation in GA patients.
-
#85
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a key center for retinal clinical trials and imaging research, with expertise in evaluating novel therapies for GA and AMD, including long-term safety and efficacy assessments.
